This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2015-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (2015)
- Edogawa-ku, JP (2019 - 2020)
Company Filing History:
Years Active: 2015-2020
Title: Innovations by Atsunobu Sakamoto
Introduction
Atsunobu Sakamoto is a notable inventor based in Edogawa-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of eye diseases. With a total of 3 patents to his name, Sakamoto's work is recognized for its innovative approach to addressing complex medical challenges.
Latest Patents
Sakamoto's latest patents focus on a sustained-release pharmaceutical composition designed for the treatment and prevention of eye diseases. His inventions involve a terpenoid derivative that activates the Keap1/Nrf2/ARE signaling pathway, showcasing excellent anti-inflammatory and cytoprotective actions. The sustained-release composition is effective for treating posterior eye diseases caused by oxidative stress. It is designed to maintain pharmacological action for one week or longer, ensuring a prolonged therapeutic effect. This innovative approach includes a base material that is administrable to the vitreous body, enhancing the delivery and efficacy of the treatment.
Career Highlights
Atsunobu Sakamoto is affiliated with Daiichi Sankyo Company, Limited, where he continues to develop groundbreaking pharmaceutical solutions. His work has been instrumental in advancing the understanding and treatment of eye diseases, contributing to the overall improvement of patient care in this area.
Collaborations
Sakamoto has collaborated with esteemed colleagues such as Yuji Kasuya and Yasuhiro Nakagami. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their research.
Conclusion
Atsunobu Sakamoto's contributions to the field of pharmaceuticals, particularly in eye disease treatment, highlight his role as a leading inventor. His innovative patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile